Oral nanozyme treats colitis-linked mental disorders via gut-brain axis

Feb 19, 2026 Oral polysaccharide-engineered nanozyme treats colitis-linked mental disorders by targeting oxidative stress and gut dysbiosis via the microbiome-gut-brain axis. (Nanowerk News) Collaborative research teams from Yangzhou University and Nanjing University have developed an oral polysaccharide-engineered nanozyme to treat colitis-associated mental disorders. The study (Advanced Materials, "Polysaccharide Engineered Nanozymes...